Pamela Ann Connealy - 22 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
CFO and COO
Signature
/s/ Pamela Connealy
Issuer symbol
PYXS
Transactions as of
22 Sep 2023
Net transactions value
+$8,695
Form type
4
Filing time
22 Sep 2023, 19:34:33 UTC
Previous filing
08 Sep 2023
Next filing
25 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Purchase $8,695 +5,000 +0.64% $1.74 792,106 22 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased all 5,000 shares of common stock in the open market at a price of $1.739 per share.